{"disease":{"id":"moderate-or-severe-submental-fullness","name":"moderate or severe submental fullness"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03982225","title":"Evaluate the Efficacy and Safety of Polyene Phosphatidylcholine Injection (AYP-101) for the Reduction of Submental Fat","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":143,"lead_sponsor_name":"AMIpharm Co., Ltd.","has_results":false},{"nct_id":"NCT05266729","title":"Determine the Dosing Interval and Optimal Dose of AYP-101 for the Reduction of Submental Fat in Chin Area","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"AMIpharm Co., Ltd.","has_results":false},{"nct_id":"NCT06756490","title":"A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat Accumulation","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Sichuan Huiyu Pharmaceutical Co., Ltd","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}